The association of oxidative stress and nasal polyposis

Journal of International Medical Research

Volumn 37, Issue 2, 2009, Pages 325-330

  Çekin, Engin ^a   Ipcioglu, O M ^a   Erkul, B E ^a   Kapucu, B ^a   Ozcan, O ^a   Cincik, H ^a   Gungor, A ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Malondialdehyde; Nasal polyposis; Nitric oxide; Oxidative stress; Superoxide dismutase

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; OXIDATIVE STRESS; RISK ASSESSMENT; RISK FACTOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYMOLOGY; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ADULT; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; NASAL POLYPS; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 66649119842     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700206     Document Type: Article

References (19)

1. Tos M, Mogensen C: Pathogenesis of nasal polyps. Rhinology 1977; 15: 87-95.
2. Drake-Lee AB: The pathogenesis of nasal polyps. In: Nasal Polyps: Epidemiology Pathogenesis and Treatment (Settipane GA, Lund VJ, Bernstein JM, et al, eds). Rhode Island: Oceanside Publications, 1997: pp 17-64.
3. Dagli M, Eryilmuz A, Besler T, et al: Role of free radicals and antioxidants in nasal polyps. Laryngoscope 2004; 114: 1200-1203.
4. Persson CG, Svensson C, Greiff L, et al: The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992; 47: 993-1000.
5. Cheng YK, Hwang GY, Lin CD, et al: Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients. Laryngoscope 2006; 116: 417-422.
6. Zheng S, Xu W, Bose S, et al: Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am J Physiol Lung Cell Mol Physiol 2004; 287: L374-L381.
7. Mannick JB: Immunoregulatory and antimicrobial effects of nitrogen oxides. Proc Am Thorac Soc 2006; 3: 161-165.
8. Nunokawa Y, Ianaka S: Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 1992; 188: 409-415.
9. Nakaki T, Nakayama M, Kato R: Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990; 189: 347-353.
10. Pryor WA, Houk KN, Foote CS, et al: Free radical biology and medicine: it's a gas, man. Am J Physiol Regul Integr Comp Physiol 2006; 291: R491-R511.
11. Colantonio D, Brouillette L, Parikh A, et al: Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy 2002: 32: 698-701.
12. Pasto M, Serrano E, Urocoste E, et al: Nasal polyp-derived superoxide anion: dose-dependent inhibition by nitric oxide and pathophysiological implications. Am J Respir Crit Care Med 2001; 163: 145-151.
13. Ruffoli R, Ursino F, Fattori B, et al: Distribution of 3-nitrotyrosine in the nasal polyps of atopic patients. Laryngoscope 2004; 114: 118-125.
14. Bowler RP, Crapo JD: Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002; 110: 349-356.
15. Dogru H, Delibaş N, Döner F, et al: Free radical damage in nasal polyp tissue. Otolaryngol Head Neck Surg 2001; 124: 570-572.
16. Arnal JF, Flores P, Rami J, et al: Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999; 13: 307-312.
17. Takeno S, Osada R, Furukido K, et al: Increased nitric oxide production in nasal epithelial cells from allergic patients - RT-PCR analysis and direct imaging by a fluorescence indicator: DAF-2 DA. Clin Exp Allergy 2001; 31: 881-888.
18. Kawamoto H, Takumida M, Takeno S, et al: Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol Suppl 1998; 539: 65-70.
19. Davis W Jr, Ronai Z, Tew KD: Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 2001; 296: 1-6.